Hepatitis C Therapy - Peregrine Pharmaceuticals, Inc. (PPHM) Names Leading Viral Experts To Its Scientific Resource Board

Peregrine Pharmaceuticals, Inc. (PPHM) Names Leading Viral Experts To Its Scientific Resource Board
BioSpace - a Phase I clinical trial for the treatment of chronic hepatitis C infection (HCV) and is being studied preclinically for

Peregrine Pharmaceuticals Names Leading Viral Experts to Its Scientific Resource Board
PR Newswire - a Phase I clinical trial forthe treatment of chronic hepatitis C infection (HCV) and is being studiedpreclinically for

Biolex Therapeutics Announces Initiation of Phase 1 Clinical Study of Hepatitis C Candidate Locteron(TM)
Drug News Wire - for the treatment of patients with chronic hepatitis C. Locteron combines BLX-883, a standard treatment for patients with chronic hepatitis C is pegylated alfa interferon

MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of Celgosivir in Combination with PEGETRO
PR Newswire via Yahoo! - 1 inhibitor, in development for the treatment of chronic hepatitis C virus (HCV) infections treatment for patients suffering from chronic hepatitis C infections.'About MX-3253